Texas Children's Hospital, Baylor College of Medicine
Welcome,         Profile    Billing    Logout  
 9 Trials 
8 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Muscal, Jodi
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
2
105
Europe, Japan, US, RoW
Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide
Eli Lilly and Company
Neoplasms, Child, Adolescent
05/27
05/27
NCT03654716: Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

Completed
1
21
US
ALRN-6924, Cytarabine, Cytosar
Dana-Farber Cancer Institute, TeamConnor Childhood Cancer Foundation, Cookies for Kids' Cancer, Aileron Therapeutics, Inc.
Leukemia, Brain Tumor, Solid Tumor, Lymphoma
07/23
07/23
McMullen-Jackson, Chivon D
NCT05406583: A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Recruiting
1
36
US, RoW
Dolutegravir 0.5 mg/kg oral suspension, DTG, Dolutegravir 5 mg Dispersible Tablets
National Institute of Allergy and Infectious Diseases (NIAID), ViiV Healthcare, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)
HIV
09/25
11/25
NCT04518228: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

Recruiting
N/A
325
US, RoW
Bictegravir (BIC), Tenofovir alafenamide (TAF), Cabotegravir (CAB), Dolutegravir (DTG), Atazanavir/ritonavir (ATV/r), Darunavir/ritonavir (DRV/r), Lopinavir/ritonavir (LPV/r), Cobicistat, Ritonavir, First-Line TB Treatment, Second-Line TB Treatment, Doravirine (DOR)
National Institute of Allergy and Infectious Diseases (NIAID), International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme LLC
HIV Infections, Tuberculosis
03/26
03/26
Satter, Lisa Forbes
NCT05438407 / 2022-001624-14: Pediatric Patients Aged 4 to 11 Years with APDS

Active, not recruiting
3
15
Europe, Japan, US
Leniolisib
Pharming Technologies B.V., CMIC Co, Ltd. Japan, Labcorp Central Laboratory, Fortrea, Aixial Group
APDS
07/25
12/25
NCT05693129: Pediatric Patients Aged 1 to 6 Years with APDS

Recruiting
3
15
Europe, Japan, US
Leniolisib
Pharming Technologies B.V., CMIC Co, Ltd. Japan, Labcorp Central Laboratory, Fortrea, Aixial Group
APDS
09/25
02/26
NCT03906318: Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

No Longer Available
N/A
NA
Iticitinib
Incyte Corporation
Aplastic Anemia
 
 
NCT05561985: Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Available
N/A
NA
Itacitinib, INCB039110
Incyte Corporation
STAT1 Gain-of-Function Disease
 
 
Patniyot, Irene
No trials found
Aina, Titilopemi
No trials found

Download Options